Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats

American Journal of Hypertension

Volumn 14, Issue 1, 2001, Pages 54-61

  Blezer, Erwin L A ^a,b   Nicolay, Klaas ^b   Koomans, Hein A ^a   Joles, Jaap A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angiotensin converting enzyme inhibitor; Angiotensin II receptor antagonist; Cerebral edema; Magnetic resonance imaging; Proteinuria; Stroke prone spontaneously hypertensive rat

Indexed keywords

ENALAPRIL; LOSARTAN;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN EDEMA; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; TARGET ORGAN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; DRUG ADMINISTRATION SCHEDULE; ENALAPRIL; GENETIC PREDISPOSITION TO DISEASE; HYPERTENSION; LOSARTAN; MALE; PROTEINURIA; RATS; RATS, INBRED SHR; SURVIVAL ANALYSIS;

EID: 0035139989     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)01231-0     Document Type: Article

References (41)

1. Symptomatological classification in the development of stroke in stroke-prone spontaneously hypertensive rats
2. Genetic predisposition to stroke in spontaneously hypertensive rats
3. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet
4. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats
5. The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopriltreated hypertensive rats
6. Losartan prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats
7. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect
8. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats
9. The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins
10. Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats
11. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats
12. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat
13. Plasma angiotensins and blood pressure during converting enzyme inhibition
14. 1-receptor antagonist, in stroke-prone spontaneously hypertensive rats
15. Angiotensin II-forming pathways in normal and failing human hearts
16. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: Role of two different angiotensin II-generating enzymes
17. MRI-based quantification of cerebral edema in individual SHRSP rats using averaged criteria determined before the occurrence of edema
18. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade
19. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats
20. Normalizing the expression of nitric oxide synthase by low dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats
21. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats
22. A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats
23. Angiotensinogen depletion by high renin levels in hypertensive rats: No evidence for tonic stimulation of angiotensinogen by angiotensin II
24. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats
25. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats
26. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats
27. Effects of antihypertensive treatment on composition of cerebral arterioles
28. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier
29. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats
30. NADH/NADPH oxidase and vascular function
31. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells
32. 2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins
33. Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy
34. 2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: Agonist effects of CGP 42112 and PD 123319
35. The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat
36. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors
37. ω-nitroarginine
38. Blockade of Bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats
39. Effect of angiotensin II receptor antagonist on albuminuria and renal function in passive Heymann nephritis
40. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms
41. High-protein diets augment albuminuria in rats with passive Heymann nephritis by angiotensin II-dependent and -independent mechanisms